vs
Side-by-side financial comparison of Citius Pharmaceuticals, Inc. (CTXR) and INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM). Click either name above to swap in a different company.
INTELLIGENT PROTECTION MANAGEMENT CORP. is the larger business by last-quarter revenue ($6.1M vs $3.9M, roughly 1.6× Citius Pharmaceuticals, Inc.).
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing innovative prescription therapies addressing unmet medical needs across critical care, oncology, anti-infective treatment, and supportive care segments, primarily serving the U.S. healthcare market.
Intelligent Limited is a Holding Company and Parent company headquartered in Gloucestershire, United Kingdom and was incorporated on 21 May 2008. Intelligent Limited provides a group management structure for four companies and was born out of the operations of International Intelligence Limited, a company specialising in Intelligence, Counter Espionage and TSCM sweeping.
CTXR vs IPM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $6.1M |
| Net Profit | $-9.4M | — |
| Gross Margin | 80.0% | 53.1% |
| Operating Margin | -228.7% | -13.4% |
| Net Margin | -238.2% | — |
| Revenue YoY | — | 2091.6% |
| Net Profit YoY | 8.6% | — |
| EPS (diluted) | $-0.38 | $-0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9M | $6.1M | ||
| Q3 25 | — | $6.2M | ||
| Q2 25 | — | $5.7M | ||
| Q1 25 | — | $5.5M | ||
| Q4 23 | — | $-7.3M | ||
| Q3 23 | — | $2.8M | ||
| Q2 23 | — | $3.0M | ||
| Q1 23 | — | $2.6M |
| Q4 25 | $-9.4M | — | ||
| Q3 25 | — | $-1.1M | ||
| Q2 25 | — | $-1.1M | ||
| Q1 25 | — | $808.5K | ||
| Q4 23 | — | — | ||
| Q3 23 | — | $-181.6K | ||
| Q2 23 | — | $135.6K | ||
| Q1 23 | — | $-738.3K |
| Q4 25 | 80.0% | 53.1% | ||
| Q3 25 | — | 50.7% | ||
| Q2 25 | — | 50.1% | ||
| Q1 25 | — | 55.3% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | 70.1% | ||
| Q2 23 | — | 73.8% | ||
| Q1 23 | — | 68.7% |
| Q4 25 | -228.7% | -13.4% | ||
| Q3 25 | — | -23.0% | ||
| Q2 25 | — | -19.7% | ||
| Q1 25 | — | -24.2% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | -14.1% | ||
| Q2 23 | — | -9.4% | ||
| Q1 23 | — | -35.5% |
| Q4 25 | -238.2% | — | ||
| Q3 25 | — | -17.4% | ||
| Q2 25 | — | -18.3% | ||
| Q1 25 | — | 14.7% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | -6.6% | ||
| Q2 23 | — | 4.6% | ||
| Q1 23 | — | -28.8% |
| Q4 25 | $-0.38 | $-0.05 | ||
| Q3 25 | — | $-0.08 | ||
| Q2 25 | — | $-0.08 | ||
| Q1 25 | — | $0.06 | ||
| Q4 23 | — | $-0.03 | ||
| Q3 23 | — | $-0.02 | ||
| Q2 23 | — | $0.01 | ||
| Q1 23 | — | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.7M | $5.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $80.0M | $18.2M |
| Total Assets | $140.4M | $26.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.7M | $5.6M | ||
| Q3 25 | — | $7.3M | ||
| Q2 25 | — | $7.3M | ||
| Q1 25 | — | $9.7M | ||
| Q4 23 | — | $13.6M | ||
| Q3 23 | — | $13.7M | ||
| Q2 23 | — | $13.7M | ||
| Q1 23 | — | $13.9M |
| Q4 25 | $80.0M | $18.2M | ||
| Q3 25 | — | $18.8M | ||
| Q2 25 | — | $19.9M | ||
| Q1 25 | — | $21.1M | ||
| Q4 23 | — | $20.1M | ||
| Q3 23 | — | $20.4M | ||
| Q2 23 | — | $20.5M | ||
| Q1 23 | — | $20.3M |
| Q4 25 | $140.4M | $26.0M | ||
| Q3 25 | — | $27.2M | ||
| Q2 25 | — | $29.8M | ||
| Q1 25 | — | $31.1M | ||
| Q4 23 | — | $23.9M | ||
| Q3 23 | — | $24.1M | ||
| Q2 23 | — | $24.4M | ||
| Q1 23 | — | $24.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.0M | $87.6K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-13.0M | $87.6K | ||
| Q3 25 | — | $133.0K | ||
| Q2 25 | — | $-888.7K | ||
| Q1 25 | — | $1.7M | ||
| Q4 23 | — | $-99.0K | ||
| Q3 23 | — | $16.1K | ||
| Q2 23 | — | $-193.8K | ||
| Q1 23 | — | $-803.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.16× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | -1.43× | ||
| Q1 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTXR
Segment breakdown not available.
IPM
| Procurement Revenue | $5.4M | 88% |
| Other | $743.9K | 12% |
